Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lithium Carbonate in Chronic Spinal Cord Injuries
NCT00750061Phase 2Completed
- Sponsor
- China Spinal Cord Injury Network
- Start
- Aug 2008
- Primary completion
- May 2010
- Modality
- DNA Intercalators/Alkylators
- Countries
- 2
01
Overview
Phase 2, randomised, double-blind trial in spinal cord injury (SCI) comparing Lithium carbonate with Placebo (2 arms). Primary endpoint: Changes of Neurological Scores from Baseline at 6 months. Started Aug 2008; status: completed.
02
Drugs
lithium carbonate
03
Conditions
spinal cord injury (SCI)
Beyond the preview
Go deeper on NCT00750061.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00750061.